Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Nemucore Remove


July 2016
SaFrThWeTuMoSu
30292827262524

Public Company News

Business Press Releases

Nemucore Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

All Press Releases

By Nemucore Medical Innovations, Inc.
Presentation on October 21, 2015 at 11:30 a.m. PDT / 2:30 p.m. EDT
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of molecularly targeted therapies to treat multidrug resistant cancers, today announced the appointment of Daniel E.
By Nemucore Medical Innovations, Inc.
Election of James B Farinholt Jr. Gives Nemucore's Board a Majority of Independent Directors
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of molecularly targeted therapies to treat multidrug resistant cancers, today announced the publication of its paper "EGFR...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..
By Nemucore Medical Innovations, Inc.
NMI's Co-Founder Dr. Torchilin was named the recipient of the Journal of Drug Targeting’s Lifetime Achievement Award for 2012 for his work in multifunctional pharmaceutical nanocarriers.
By Nemucore Medical Innovations
Nemucore Medical Innovations, as part of Northeastern University’s Center of Cancer Nanotechnology Excellence (CCNE) consortium, will develop nanomedicine manufacturing processes under recent $13.5 million grant from the National Cancer Institute

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share